Agnes M. Looijen
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA) trial: a multicentre, open-label, randomised controlled trial comparing routine care with a tailor-made approach.
Journal: BMJ open
Published: December 18, 2025
Development and validation of a model to predict the disease activity score: towards a remote treat-to-target approach for rheumatoid arthritis.
Journal: Annals of the rheumatic diseases
Published: September 30, 2025
The Association Between Serum Drug Concentration and a Flare in Rheumatoid Arthritis Patients Tapering TNF Inhibitors.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 11, 2025
Eye-openers for advanced management of elderly-onset rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: February 18, 2025
Sex Differences in Rheumatoid Arthritis: New Insights From Clinical and Patient-Reported Outcome Perspectives.
Journal: The Journal of rheumatology
Published: January 24, 2025
The prognostic value of IgA anti-citrullinated protein antibodies and rheumatoid factor in an early arthritis population with a treat-to-target approach.
Journal: Immunologic research
Published: February 29, 2024
Patient-reported outcomes and radiographic progression in patients with rheumatoid arthritis in sustained remission versus low disease activity.
Journal: RMD open
Published: October 30, 2023
Responsiveness and sensitivity of PROMs to change in disease activity status in early and established rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: September 01, 2023
Patients with rheumatoid arthritis presenting with mono- or oligo-arthritis and high VAS-ratings remain the most fatigued during 5 years of follow-up.
Journal: Rheumatology (Oxford, England)
Published: February 01, 2023
Last Updated: 09/26/2026